Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.2%

19 terminated/withdrawn out of 367 trials

Success Rate

89.7%

+3.1% vs industry average

Late-Stage Pipeline

13%

48 trials in Phase 3/4

Results Transparency

4%

7 of 165 completed trials have results

Key Signals

45 recruiting7 with results15 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
161(57.5%)
Phase 2
53(18.9%)
Phase 4
34(12.1%)
Phase 1
16(5.7%)
Phase 3
14(5.0%)
Early Phase 1
2(0.7%)
280Total
N/A(161)
Phase 2(53)
Phase 4(34)
Phase 1(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (367)

Showing 20 of 367 trials
NCT07703280Phase 2Not Yet Recruiting

Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis

Role: collaborator

NCT05429827Not ApplicableCompleted

The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome

Role: lead

NCT04137939Not ApplicableRecruiting

The Effect of IoT-based Smart Exercises System in the Senior Adults

Role: lead

NCT07679191Not ApplicableNot Yet Recruiting

Topical Application of Sucralfate in Promoting Healing of Esophageal Ulcers After Esophageal Varices Ligation

Role: lead

NCT05170438Phase 2Active Not Recruiting

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

Role: collaborator

NCT05026905Phase 2Active Not Recruiting

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Role: collaborator

NCT05036486Active Not Recruiting

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Role: collaborator

NCT04821895Active Not Recruiting

Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

Role: collaborator

NCT06981637Phase 2Recruiting

Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)

Role: collaborator

NCT05522881Recruiting

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

Role: collaborator

NCT07679139Not ApplicableNot Yet Recruiting

Endoscopic Application of Hemostatic Drug Powder in Lower Gastrointestinal Bleeding: A Pilot Study

Role: lead

NCT07656389Not Yet Recruiting

An AI-Based Prediction of Cognitive Capacity in Older Adults and Individuals With Mild Cognitive Impairment During Virtual Reality Driving Tasks

Role: lead

NCT07262411Not ApplicableActive Not Recruiting

Peer-based Recovery Program

Role: lead

NCT06340789Phase 2Recruiting

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Role: lead

NCT07525713Not ApplicableRecruiting

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Role: lead

NCT06897267Not ApplicableCompleted

The Feasibility of the Peer-based Recovery Program

Role: lead

NCT06716086Not ApplicableCompleted

A Novel Shape Memory Alloy-Based Orthosis for Proximal Interphalangeal Joint Stiffness

Role: lead

NCT01194518Not ApplicableCompleted

Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKD

Role: collaborator

NCT05977296Not ApplicableCompleted

Obstructive Sleep Apnea (OSA), Oral Frailty, Dysphagia, Continuous Positive Airway Pressure (CPAP)

Role: lead

NCT06456450Recruiting

Taiwan Severe Asthma Biologic Registry

Role: collaborator